trial · primary record
Empagliflozin
End-stage Kidney Disease
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 62 |
| Primary completion | 2025-06-30 |
| Primary endpoint | Study Completion |
| Registry ID | NCT05614115 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:44.891Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05614115
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Empagliflozin · approval
- EMPAGLIFLOZIN · catalyst
- Empagliflozin · compound